Profiel
Ram Waisbourd worked as VP-Strategy, Transformation & Global Research at Teva Pharmaceutical Industries Ltd.
from 2016 to 2018.
Prior to that, he was Vice President-Business Development at XTL Biopharmaceuticals Ltd.
Mr. Waisbourd's most recent job was as Chief Operating & Business Officer at 89bio, Inc. from 2018 to 2022.
Mr. Waisbourd holds an MBA from Tel-Aviv University and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Eerdere bekende functies van Ram Waisbourd
| Bedrijven | Functie | Einde |
|---|---|---|
| 89BIO, INC. | Chief Operating Officer | 01-06-2022 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Tech/Sci/R&D Officer | 01-04-2018 |
| XTL BIOPHARMACEUTICALS LTD. | Corporate Officer/Principal | - |
Opleiding van Ram Waisbourd
| Tel-Aviv University | Masters Business Admin |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| 89BIO, INC. | Health Technology |
